Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$12.4 - $17.6 $124,000 - $176,000
-10,000 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$11.59 - $14.93 $53,314 - $68,678
-4,600 Reduced 31.51%
10,000 $132,000
Q2 2020

Aug 12, 2020

SELL
$11.79 - $15.97 $3,536 - $4,791
-300 Reduced 2.01%
14,600 $183,000
Q1 2020

May 12, 2020

BUY
$9.31 - $21.24 $42,826 - $97,704
4,600 Added 44.66%
14,900 $200,000
Q4 2019

Jan 27, 2020

BUY
$13.91 - $21.48 $143,273 - $221,244
10,300 New
10,300 $206,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $292M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.